Epigral Ltd. (EPIGRAL) — Cash Flow Reinvestment Rate
Epigral Ltd. (EPIGRAL) has a Cash Flow Reinvestment Rate of 0.88x as of September 2025, reinvesting Rs2.36 Billion (capex Rs2.36 Billion ) from operating cash flow of Rs2.67 Billion. See EPIGRAL cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Epigral Ltd. Cash Flow Reinvestment Rate (2015–2026)
Historical reinvestment intensity for Epigral Ltd. across 12 annual periods. For the full cash flow conversion analysis, see Epigral Ltd. (EPIGRAL) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Epigral Ltd. (2015–2026)
Year-by-year capital reinvestment analysis for Epigral Ltd.. See financial flexibility index of Epigral Ltd. to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 1.09x | Rs4.21 Billion | Rs3.88 Billion | Rs3.94 Billion | ▲ +77.2% |
| 2025 | 0.61x | Rs2.70 Billion | Rs4.41 Billion | Rs1.95 Billion | ▼ -39.2% |
| 2024 | 1.01x | Rs4.01 Billion | Rs3.98 Billion | Rs3.98 Billion | ▲ +51.7% |
| 2023 | 0.67x | Rs4.16 Billion | Rs6.26 Billion | Rs4.16 Billion | ▼ -58.8% |
| 2022 | 1.61x | Rs4.58 Billion | Rs2.84 Billion | Rs4.56 Billion | ▲ +87.8% |
| 2021 | 0.86x | Rs1.97 Billion | Rs2.29 Billion | Rs1.97 Billion | ▼ -61.7% |
| 2020 | 2.24x | Rs3.69 Billion | Rs1.65 Billion | Rs3.69 Billion | ▲ +93.6% |
| 2019 | 1.16x | Rs3.03 Billion | Rs2.61 Billion | Rs3.03 Billion | ▲ +110.9% |
| 2018 | 0.55x | Rs1.23 Billion | Rs2.25 Billion | Rs1.23 Billion | ▲ +117.6% |
| 2017 | 0.25x | Rs349.30 Million | Rs1.38 Billion | Rs349.30 Million | ▼ -46.8% |
| 2016 | 0.47x | Rs585.42 Million | Rs1.23 Billion | Rs585.42 Million | ▲ +1443.4% |
| 2015 | 0.03x | Rs34.48 Million | Rs1.12 Billion | Rs34.48 Million | — |